Probiotics After Antibiotics: What to Take and When (2026)
Updated June 2026 · Sources: Szajewska & Kolodziej 2015, Palleja 2018, Cleveland Clinic, NIH ODS
Quick summary: the evidence-backed protocol
- Start S. boulardii CNCM I-745 (Florastor) on Day 1 of your antibiotic course. 250-500 mg twice daily. No separation needed - it is a yeast.
- Add L. rhamnosus GG (Culturelle) if you want bacterial probiotic support. Take 2-3 hours from your antibiotic dose.
- Continue both for 2-4 weeks after the antibiotic course ends.
- Eat prebiotic-rich foods throughout: oats, legumes, cooked and cooled potatoes, garlic (if tolerated). Avoid high-sugar diet which depletes Bifidobacterium.
How Antibiotics Affect the Gut Microbiome
Antibiotics are designed to kill bacteria. They do not distinguish beneficial resident gut bacteria from the pathogen being treated. A standard 7-day course of broad-spectrum antibiotics (amoxicillin, ciprofloxacin, clindamycin) can:
- Reduce total gut bacterial diversity by 30-60%
- Reduce Bifidobacterium and Lactobacillus counts by 2-3 log units (99-99.9% reduction)
- Create overgrowth niches for Clostridium, Candida, and antibiotic-resistant bacteria
- Impair short-chain fatty acid (SCFA) production, reducing butyrate-mediated colon cell protection
Recovery time: a 2018 study (Palleja et al., Nature Microbiology 2018) followed healthy adults given a short broad-spectrum antibiotic course and found the gut microbiota recovered to near-baseline within about 1.5 months, but several common species were still missing at 6 months. Recovery is substantial but not always complete. Antibiotic-associated diarrhoea (AAD) affects 5-35% of patients taking antibiotics; this incidence varies significantly by antibiotic type, with clindamycin having the highest AAD rate.
Evidence-Graded Probiotic Recommendations
S. boulardii CNCM I-745 (Florastor) - First Choice
Strong EvidenceThe standout option. A 2015 meta-analysis (Szajewska & Kolodziej, Aliment Pharmacol Ther 2015) of 21 RCTs (4,780 patients) found S. boulardii roughly halves the risk of AAD (RR 0.47, 95% CI 0.38-0.57), cutting it from about 19% to 9% (NNT 10), with benefit in both children and adults. The critical advantage: S. boulardii is a yeast and is completely unaffected by antibiotics. You can - and should - take it simultaneously with your antibiotic.
Cite: Szajewska & Kolodziej, Aliment Pharmacol Ther 2015;42(7):793-801; McFarland, World J Gastroenterol 2010
L. rhamnosus GG (Culturelle) - Second Choice
Strong EvidenceThe best bacterial option. Multiple RCTs show LGG reduces AAD risk compared to placebo, with effect size smaller than S. boulardii but clinically meaningful. The key limitation: LGG is a bacterium and is sensitive to most antibiotics. Separate LGG from antibiotic doses by at least 2-3 hours to allow the probiotic to transit through the GI tract before the antibiotic depletes it.
Cite: Szajewska & Kolodziej, Aliment Pharmacol Ther 2015;42(10):1149-57
S. boulardii + LGG Combined
Emerging EvidenceSome clinicians recommend both simultaneously for high-risk cases (clindamycin or fluoroquinolone antibiotics, elderly patients, history of C. diff). The combination provides both the direct anti-infective mechanism of S. boulardii and the mucosal barrier-restoring effect of LGG. No large RCT has tested the combination directly; the recommendation is extrapolated from individual strain evidence.
C. difficile Prevention: Higher-Risk Antibiotics
Clostridium difficile (C. diff) is the most serious complication of antibiotic-associated microbiome disruption. C. diff produces toxins A and B that cause colitis; in severe cases, it can be life-threatening. Antibiotic-associated C. diff most commonly follows clindamycin, fluoroquinolones (ciprofloxacin, levofloxacin), and broad-spectrum cephalosporins and penicillins.
S. boulardii CNCM I-745 has specific anti-C. diff evidence: it secretes a 54 kDa protease that cleaves both C. diff toxin A receptor binding domain and toxin B. This mechanism is unique to S. boulardii. Multiple RCTs and clinical guidelines (Cleveland Clinic, ESCMID) support its use as adjunct prophylaxis during high-risk antibiotic courses.
If you have had C. diff infection previously, the recurrence risk with a subsequent antibiotic course is 20-25%. S. boulardii is the most evidence-supported adjunct in this recurrence-prevention scenario. Discuss with your prescribing clinician.
Dietary Support During and After Antibiotics
Probiotics work best alongside a diet that supports microbiome recovery. Key dietary strategies:
- Prebiotic-rich foods: Oats, barley, legumes (lentils, chickpeas), garlic and onion (if tolerated), asparagus, green bananas. These feed the recovering Bifidobacterium and Lactobacillus populations.
- Cooked and cooled starches: Cold potato, cold rice, and cold pasta have higher resistant starch content and provide excellent prebiotic substrate.
- Live-culture fermented foods: Yogurt (live cultures), kefir, kimchi, sauerkraut. Increase their frequency during antibiotic recovery.
- Reduce refined sugar and ultra-processed food: High sugar diets selectively feed Candida and displace Bifidobacterium. This is particularly important during and after antibiotics.
- Avoid excess alcohol: Alcohol disrupts the mucosal barrier and suppresses Bifidobacterium growth. Minimise during recovery.
When Symptoms Require Medical Attention
Antibiotic-associated diarrhoea (AAD) is common and often self-limiting. C. difficile colitis requires medical treatment (metronidazole or vancomycin). Seek urgent medical care if you develop:
- Watery diarrhoea more than 3 times per day
- Blood or mucus in stool
- Fever above 38.5C (101.3F)
- Severe abdominal cramping or tenderness
- Symptoms persisting for more than 3 days after antibiotic course ends